Let’s say, for example, your father was diagnosed with prostate cancer and referred to a clinical investigation site for a new investigational treatment. How would…
Recently, TrialSite News initiated a research project that offers patients and sponsorsvaluable information regarding many clinical investigation sites. This information isn’t easily found, but our…
Private-equity-infused clinical investigational sites continue to scour America and beyond for acquisitions—seeking scale, diverse therapeutic capability and patient access for CROs and biopharmaceutical sponsors. Now,…
The Clinical investigational site market continues to get more interesting by the day. Private equity-backed Velocity Clinical Research, led by industry veteran Paul Evans, acquired more…
TrialSite News researchers are providing a service unlike any other: much-awaited consumer information surrounding clinical trials that treat a range of diseases and conditions. In…
TrialSite News is on a mission to procure and provide to our readers the necessary knowledge to making decisions about their clinical trial participation and…
In an ongoing effort to provide our readers the most relevant and useful news regarding clinical research, we are covering Integrity Clinical Research in Doral,…
TrialSite News has embarked on a research project unlike any other—inquiring a solid, transparent and patient-centric summary of clinical research sites involved in the clinical…
TrialSite News has monitored how industry sponsors and clinical research organizations (CROs) increasingly covet direct engagement with valuable clinical investigational sites. After all, it is…
Rafael Pharmaceuticals reported that 25 sites have been activated in the pivotal Phase III ARMADA 2000 clinical trial of CPI613® (devimistat) in older patients with…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
